OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanobodies: new avenue to treat kidney disease
Nicola Wanner, Thomas Watts Eden, Nastassia Liaukouskaya, et al.
Cell and Tissue Research (2021) Vol. 385, Iss. 2, pp. 445-456
Open Access | Times Cited: 9

Showing 9 citing articles:

AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Niels Vandewalle, Hatice Satilmis, Emma Verheye, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2656-2674
Open Access | Times Cited: 5

Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons
Soha S. Rizk, Dina Mohamed Moustafa, Shahira A. ElBanna, et al.
World Journal of Microbiology and Biotechnology (2024) Vol. 40, Iss. 7
Open Access | Times Cited: 3

Neutralizing Antibodies Targeting BK Polyomavirus
François Helle, Aurélien Aubry, Virginie Morel, et al.
Journal of the American Society of Nephrology (2024) Vol. 35, Iss. 10, pp. 1425-1433
Closed Access | Times Cited: 3

COVID‐19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms
Yu Zheng, Yuke Li, Li Mao, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 738-811
Closed Access | Times Cited: 9

Multi-Target Drugs for Kidney Diseases
John D. Imig, Daniel Merk, Eugen Proschak
Kidney360 (2021) Vol. 2, Iss. 10, pp. 1645-1653
Open Access | Times Cited: 15

Characterization of novel CD19-specific VHHs isolated from a camelid immune library by phage display
Mahmoud Ganji, Pooria Safarzadeh Kozani, Fatemeh Rahbarizadeh
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5

Single domain Camelid antibody fragments for molecular imaging and therapy of cancer
Shulin Li, Sanne Hoefnagel, Kausilia K. Krishnadath
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2

Immune-mediated glomerular diseases: new basic concepts and clinical implications
Ulf Panzer, Tobias B. Huber
Cell and Tissue Research (2021) Vol. 385, Iss. 2, pp. 277-279
Open Access | Times Cited: 4

Filtration and tubular handling of EWE‐hC3Nb1, a complement inhibitor nanobody, in wild type mice and a mouse model of proteinuric kidney disease
M Fast, Kathrin Weyer, Henrik Pedersen, et al.
FEBS Open Bio (2023) Vol. 14, Iss. 2, pp. 322-330
Open Access | Times Cited: 1

Page 1

Scroll to top